Application 083220

Type
ANDA
Sponsor
PHARMACIA AND UPJOHN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OGEN .625ESTROPIPATETABLET;ORAL0.75MGNoNo
002OGEN 1.25ESTROPIPATETABLET;ORAL1.5MGNoNo
003OGEN 2.5ESTROPIPATETABLET;ORAL3MGNoNo
004OGEN 5ESTROPIPATETABLET;ORAL6MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A083220-001OGEN .625ESTROPIPATE0.75MGTABLET / ORALRLD, Approved before 1982
A083220-002OGEN 1.25ESTROPIPATE1.5MGTABLET / ORALRLD, Approved before 1982
A083220-003OGEN 2.5ESTROPIPATE3MGTABLET / ORALRLD, Approved before 1982
A083220-004OGEN 5ESTROPIPATE6MGTABLET / ORALRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 5 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10A083220-001OGEN .6250.75MGTABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A083220-002OGEN 1.251.5MGTABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A083220-003OGEN 2.53MGTABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A083220-004OGEN 56MGTABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A083220-001OGEN .6250.75MGTABLET / ORALRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09A083220-002OGEN 1.251.5MGTABLET / ORALRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09A083220-003OGEN 2.53MGTABLET / ORALRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09A083220-004OGEN 56MGTABLET / ORALRLD, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A083220-001OGEN .6250.75MGTABLET / ORALRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A083220-002OGEN 1.251.5MGTABLET / ORALRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A083220-003OGEN 2.53MGTABLET / ORALRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A083220-004OGEN 56MGTABLET / ORALRLD, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A083220-001OGEN .6250.75MGTABLET / ORALRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A083220-002OGEN 1.251.5MGTABLET / ORALRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A083220-003OGEN 2.53MGTABLET / ORALRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A083220-004OGEN 56MGTABLET / ORALRLD, Approved before 1982a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
18498SUPPL2009-09-30